Skip to main content
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.750
-0.080 (-2.83%)
At close: Apr 28, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Apr 28, 2026, 7:51 PM EDT

C4 Therapeutics Revenue

In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. C4 Therapeutics had revenue of $11.02M in the quarter ending December 31, 2025, with 112.79% growth.

Revenue (ttm)
$35.95M
Revenue Growth
+1.02%
P/S Ratio
7.42
Revenue / Employee
$345,644
Employees
104
Market Cap
268.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202535.95M363.00K1.02%
Dec 31, 202435.58M14.83M71.44%
Dec 31, 202320.76M-10.34M-33.25%
Dec 31, 202231.10M-14.69M-32.08%
Dec 31, 202145.79M12.59M37.93%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Compugen 72.76M
Coherus Oncology 42.17M
Editas Medicine 40.52M
AC Immune 4.51M
Artiva Biotherapeutics 251.00K
Revenue Rankings

CCCC News

More News